|
|
49, Boulevard du Gral Martial Valin, 4th Floor Paris, 75015 France phone:(33) 1 45 58 76 00 fax:(33) 1 45 58 08 81
|
|
| Symbol |
BIO |
| Exchange |
EPA |
| Founded |
0 |
| Employees |
|
|
|
| www.bioalliancepharma.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutics targeting cancer, HIV, and severe infections. |
 |
| Management |
| Jean-Marie Zacharie, Chairman; Fran?ois Sarkozy, MD, Vice Chairman; Michel Ari?, Chief Financial Officer; Georges Hibon, Gilles Marache, CEO of Amgen France and Vice-President of Amgen Inc; Philippe Taranto, Associate Director at NI Partner investment fund |
| |
|
|
|
|
|
|
|
| Keywords |
| biopharmaceutical, drug, resistance, therapeutics, cancer, hiv, infections, supportive care, radiotherapy, diabetics, elderly, ovarian, breast, lung, HIVAIDS |
|
|
|
| Description |
|
BioAlliance Pharma is focused on drug resistance through development and commercialization of innovative therapeutics, targeting markets in cancer, HIV, severe infections and supportive care. |
 |
 |
|
|
|
|
|
|